These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

629 related articles for article (PubMed ID: 28525381)

  • 41. Ccl5 establishes an autocrine high-grade glioma growth regulatory circuit critical for mesenchymal glioblastoma survival.
    Pan Y; Smithson LJ; Ma Y; Hambardzumyan D; Gutmann DH
    Oncotarget; 2017 May; 8(20):32977-32989. PubMed ID: 28380429
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Natural history of neurofibromatosis 1-associated optic nerve glioma in mice.
    Bajenaru ML; Garbow JR; Perry A; Hernandez MR; Gutmann DH
    Ann Neurol; 2005 Jan; 57(1):119-27. PubMed ID: 15622533
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Genetic driver mutations define the expression signature and microenvironmental composition of high-grade gliomas.
    Herting CJ; Chen Z; Pitter KL; Szulzewsky F; Kaffes I; Kaluzova M; Park JC; Cimino PJ; Brennan C; Wang B; Hambardzumyan D
    Glia; 2017 Dec; 65(12):1914-1926. PubMed ID: 28836293
    [TBL] [Abstract][Full Text] [Related]  

  • 44. An Overview of Optic Pathway Glioma With Neurofibromatosis Type 1: Pathogenesis, Risk Factors, and Therapeutic Strategies.
    Chen Y; Yu J; Ge S; Jia R; Song X; Wang Y; Fan X
    Invest Ophthalmol Vis Sci; 2024 Jun; 65(6):8. PubMed ID: 38837168
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Optic nerve dysfunction in a mouse model of neurofibromatosis-1 optic glioma.
    Hegedus B; Hughes FW; Garbow JR; Gianino S; Banerjee D; Kim K; Ellisman MH; Brantley MA; Gutmann DH
    J Neuropathol Exp Neurol; 2009 May; 68(5):542-51. PubMed ID: 19525901
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treatment during a developmental window prevents NF1-associated optic pathway gliomas by targeting Erk-dependent migrating glial progenitors.
    Jecrois ES; Zheng W; Bornhorst M; Li Y; Treisman DM; Muguyo D; Huynh S; Andrew SF; Wang Y; Jiang J; Pierce BR; Mao H; Krause MK; Friend A; Nadal-Nicolas F; Stasheff SF; Li W; Zong H; Packer RJ; Zhu Y
    Dev Cell; 2021 Oct; 56(20):2871-2885.e6. PubMed ID: 34428430
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Brain gliomas, hydrocephalus and idiopathic aqueduct stenosis in children with neurofibromatosis type 1.
    Glombova M; Petrak B; Lisy J; Zamecnik J; Sumerauer D; Liby P
    Brain Dev; 2019 Sep; 41(8):678-690. PubMed ID: 31000370
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Schweinfurthin A selectively inhibits proliferation and Rho signaling in glioma and neurofibromatosis type 1 tumor cells in a NF1-GRD-dependent manner.
    Turbyville TJ; Gürsel DB; Tuskan RG; Walrath JC; Lipschultz CA; Lockett SJ; Wiemer DF; Beutler JA; Reilly KM
    Mol Cancer Ther; 2010 May; 9(5):1234-43. PubMed ID: 20442305
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The molecular landscape of glioma in patients with Neurofibromatosis 1.
    D'Angelo F; Ceccarelli M; Tala ; Garofano L; Zhang J; Frattini V; Caruso FP; Lewis G; Alfaro KD; Bauchet L; Berzero G; Cachia D; Cangiano M; Capelle L; de Groot J; DiMeco F; Ducray F; Farah W; Finocchiaro G; Goutagny S; Kamiya-Matsuoka C; Lavarino C; Loiseau H; Lorgis V; Marras CE; McCutcheon I; Nam DH; Ronchi S; Saletti V; Seizeur R; Slopis J; Suñol M; Vandenbos F; Varlet P; Vidaud D; Watts C; Tabar V; Reuss DE; Kim SK; Meyronet D; Mokhtari K; Salvador H; Bhat KP; Eoli M; Sanson M; Lasorella A; Iavarone A
    Nat Med; 2019 Jan; 25(1):176-187. PubMed ID: 30531922
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Genetic and genomic alterations differentially dictate low-grade glioma growth through cancer stem cell-specific chemokine recruitment of T cells and microglia.
    Guo X; Pan Y; Gutmann DH
    Neuro Oncol; 2019 Oct; 21(10):1250-1262. PubMed ID: 31111915
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A Novel Mouse Model of Diffuse Intrinsic Pontine Glioma Initiated in Pax3-Expressing Cells.
    Misuraca KL; Hu G; Barton KL; Chung A; Becher OJ
    Neoplasia; 2016 Jan; 18(1):60-70. PubMed ID: 26806352
    [TBL] [Abstract][Full Text] [Related]  

  • 52. PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo.
    Dai C; Celestino JC; Okada Y; Louis DN; Fuller GN; Holland EC
    Genes Dev; 2001 Aug; 15(15):1913-25. PubMed ID: 11485986
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Quantitative analysis of mitotic Olig2 cells in adult human brain and gliomas: implications for glioma histogenesis and biology.
    Rhee W; Ray S; Yokoo H; Hoane ME; Lee CC; Mikheev AM; Horner PJ; Rostomily RC
    Glia; 2009 Apr; 57(5):510-23. PubMed ID: 18837053
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Oncogenic signaling is dominant to cell of origin and dictates astrocytic or oligodendroglial tumor development from oligodendrocyte precursor cells.
    Lindberg N; Jiang Y; Xie Y; Bolouri H; Kastemar M; Olofsson T; Holland EC; Uhrbom L
    J Neurosci; 2014 Oct; 34(44):14644-51. PubMed ID: 25355217
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Harnessing OLIG2 function in tumorigenicity and plasticity to target malignant gliomas.
    Kosty J; Lu F; Kupp R; Mehta S; Lu QR
    Cell Cycle; 2017 Sep; 16(18):1654-1660. PubMed ID: 28806136
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Increased Tissue Stiffness in Tumors from Mice with Neurofibromatosis-1 Optic Glioma.
    Walter C; Crawford L; Lai M; Toonen JA; Pan Y; Sakiyama-Elbert S; Gutmann DH; Pathak A
    Biophys J; 2017 Apr; 112(8):1535-1538. PubMed ID: 28445745
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mosaic analysis with double markers reveals tumor cell of origin in glioma.
    Liu C; Sage JC; Miller MR; Verhaak RG; Hippenmeyer S; Vogel H; Foreman O; Bronson RT; Nishiyama A; Luo L; Zong H
    Cell; 2011 Jul; 146(2):209-21. PubMed ID: 21737130
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Neurofibromatosis type 1 and optic pathway glioma: Molecular interplay and therapeutic insights.
    Khatua S; Gutmann DH; Packer RJ
    Pediatr Blood Cancer; 2018 Mar; 65(3):. PubMed ID: 29049847
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Subtyping of gliomas of various WHO grades by the application of immunohistochemistry.
    Popova SN; Bergqvist M; Dimberg A; Edqvist PH; Ekman S; Hesselager G; Ponten F; Smits A; Sooman L; Alafuzoff I
    Histopathology; 2014 Feb; 64(3):365-79. PubMed ID: 24410805
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Increased c-Jun-NH2-kinase signaling in neurofibromatosis-1 heterozygous microglia drives microglia activation and promotes optic glioma proliferation.
    Daginakatte GC; Gianino SM; Zhao NW; Parsadanian AS; Gutmann DH
    Cancer Res; 2008 Dec; 68(24):10358-66. PubMed ID: 19074905
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.